Request a Proposal
Welcome to Rapport, containing tips, truths, news and views, blogs, tweets, articles and films covering a range of topics currently affecting Research Partnership and the pharma market research world.
  • Posted by Mariel Metcalfe
  • November 19, 2018
  • News

Research Partnership launches new patient Living with Ankylosing Spondylitis EU and US 2019 report

Research Partnership launches new patient Living with Ankylosing Spondylitis EU and US 2019 report

Living with ankylosing spondylitis (AS) is a quantitative study conducted online amongst give the total number 365 patients diagnosed with AS in the 5 EU; up to 100 of these will be classified as likely nr-AxSpA in the 5 EU markets (France, Germany, Italy, Spain, UK). In the US, the study is conducted with 105 AS patients and 30 nr-AxSpA patients. The report consists of quantitative 30 minute quantitative online interviews and qualitative tele-depth interviews, and will be published in the 1st quarter 2019.

read more »

  • Posted by Laurent Chanroux
  • March 5, 2015
  • Articles

The impact on patient outcomes in the treatment of non-radiographic axial spondyloarthritis

The impact on patient outcomes in the treatment of non-radiographic axial spondyloarthritis

The Therapy Watch nr-axial SpA monthly study was launched in July 2014 among a panel of 200 EU5 rheumatologists to provide insight into the characteristics of nr-axSpA patients, existing treatment strategies and potential barriers to prescribing.

The Therapy Watch nr-axial SpA monthly study was launched in July 2014 among a panel of 200 EU5 rheumatologists to provide insight into the characteristics of nr-axSpA patients, existing treatment strategies and potential barriers to prescribing.Axial spondyloarthritis (axSpA) is still a relatively new term in rheumatology and the recent nomenclature separating axial vs. peripheral, and radiographic and non-radiographic spondyloarthritis has changed the perspective of ankylosing spondylitis (AS) by switching the focus towards earlier diagnosis and treatment of the disease.

read more »